Next Article in Journal
Circadian Clock and Nutrition
Previous Article in Journal
Advances in Nutrition in Pediatric Gastroenterology
Previous Article in Special Issue
Preliminary Comparison of Fractional Absorption of Zinc Sulphate, Zinc Gluconate, and Zinc Aspartate after Oral Supple-Mentation in Healthy Human Volunteers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 15
Issue 9
10.3390/nu15092182
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Uncovering the Relationship between Selenium Status, Age, Health, and Dietary Habits: Insights from a Large Population Study including Nonagenarian Offspring from the MARK-AGE Project

by
Robertina Giacconi
1,*,
Francesco Piacenza
1,
Valentina Aversano
2,
Michele Zampieri
2,
Alexander Bürkle
3,
María Moreno Villanueva
3,4,
Martijn E. T. Dollé
5,
Eugène Jansen
5,
Tilman Grune
6,7,
Efstathios S. Gonos
8,
Claudio Franceschi
9,10,
Miriam Capri
9,11,
Birgit Weinberger
12,
Ewa Sikora
13,
Olivier Toussaint
14,†,
Florence Debacq-Chainiaux
14,
Wolfgang Stuetz
15,
Pieternella Eline Slagboom
16,
Jürgen Bernhardt
17,
Maria Luisa Fernández-Sánchez
18,
Mauro Provinciali
1 and
Marco Malavolta
1add Show full author list remove Hide full author list
1
Advanced Technology Center for Aging Research, IRCCS INRCA, 60121 Ancona, Italy
2
Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy
3
Molecular Toxicology Group, Department of Biology, University of Konstanz, P.O. Box 628, 78457 Konstanz, Germany
4
Human Performance Research Centre, Department of Sport Science, Universityof Konstanz, P.O. Box 30, 78457 Konstanz, Germany
5
Centre for Health Protection, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands
6
Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), 14558 Nuthetal, Germany
7
NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam, 14458 Nuthetal, Germany
8
National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 11635 Athens, Greece
9
Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy
10
Laboratory of Systems Medicine of Healthy Aging, Institute of Biology and Biomedicine and Institute of Information Technology, Mathematics and Mechanics, Department of Applied Mathematics, Lobachevsky State University, 603105 Nizhny Novgorod, Russia
11
Interdepartmental Center—Alma Mater Research Institute on Global Challenges and Climate Change, University of Bologna, 40126 Bologna, Italy
12
Institute for Biomedical Aging Research, Universität Innsbruck, 6020 Innsbruck, Austria
13
Laboratory of the Molecular Bases of Ageing, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, Poland
14
URBC-NARILIS, University of Namur, Rue de Bruxelles, 61, 5000 Namur, Belgium
15
Institute of Nutritional Sciences, Department of Food Biofunctionality, University of Hohenheim, 70593 Stuttgart, Germany
16
Department of Molecular Epidemiology, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands
17
BioTeSys GmbH, Schelztorstr. 54–56, 73728 Esslingen, Germany
18
Department of Physical and Analytical Chemistry, Faculty of Chemistry, University of Oviedo, Julian Clavería, 8, 33006 Oviedo, Spain
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
†
Deceased.
Nutrients 2023, 15(9), 2182; https://doi.org/10.3390/nu15092182
Submission received: 28 March 2023 / Revised: 14 April 2023 / Accepted: 16 April 2023 / Published: 4 May 2023
(This article belongs to the Special Issue Trace Elements and Minerals in Aging and Age-Related Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
An inadequate selenium (Se) status can accelerate the aging process, increasing the vulnerability to age-related diseases. The study aimed to investigate plasma Se and Se species in a large population, including 2200 older adults from the general population (RASIG), 514 nonagenarian offspring (GO), and 293 GO Spouses (SGO). Plasma Se levels in women exhibit an inverted U-shaped pattern, increasing with age until the post-menopausal period and then declining. Conversely, men exhibit a linear decline in plasma Se levels with age. Subjects from Finland had the highest plasma Se values, while those from Poland had the lowest ones. Plasma Se was influenced by fish and vitamin consumption, but there were no significant differences between RASIG, GO, and SGO. Plasma Se was positively associated with albumin, HDL, total cholesterol, fibrinogen, and triglycerides and negatively associated with homocysteine. Fractionation analysis showed that Se distribution among plasma selenoproteins is affected by age, glucometabolic and inflammatory factors, and being GO or SGO. These findings show that sex-specific, nutritional, and inflammatory factors play a crucial role in the regulation of Se plasma levels throughout the aging process and that the shared environment of GO and SGO plays a role in their distinctive Se fractionation.

1. Introduction

Selenium (Se) is an essential element for human health, known for its antioxidant and immune-modulatory properties and for being the unique trace element incorporated into selenoproteins in the form of selenocysteine [1]. Se deficiency has been implicated in many conditions involving oxidative stress and inflammation, including cardiovascular diseases and cancer [2,3,4,5]. The Recommended Dietary Allowance (RDA) of Se for people above 50 years was reported around 55 µg, both in males and in females [6]. This amount of dietary Se is sufficient to promote physiological protection against oxidative stress, mainly through selenoproteins, and to reduce the risk of major pathologies associated with aging. Some studies have provided evidence for an association of circulating levels of serum Se and its antioxidant action with longevity [7,8,9,10], but the reference ranges are not well established in view of the large variations in Se status between countries [11]. Indeed, diet and the geographical area play an essential role in the presence of Se in human plasma, as demonstrated by studies comparing serum Se levels in people from areas characterized by different concentration of Se in the soil [12]. When the soil is rich in Se, the main food sources of Se (fish and seafood, cereals, whole meal bread, cereals, and white meat) contain higher levels of this trace element [13].
The total amount of Se in plasma is very important, but its subspecies are responsible for the biological activity [14,15]. The human selenoproteome contains 25 known selenoproteins (proteins that include at least a selenocysteine) [16]. Among these, selenoprotein P (SELENOP) and plasma glutathione peroxidase (GPX) are the most abundant species [17], and they play a relevant role for health status for the prevention of inflammation, cardiovascular diseases, infections, and cancer [18]. A relatively high amount was also found for the selenocompound Selenoalbumin (SeAlb), a selenium species that does not include a selenocysteine. To date, few studies have been conducted on the distribution of Se species in human blood and their correlation with overall Se levels. Moreover, while there is evidence on the decrease in circulating Se in nonagenarians and centenarians [19], no investigation has been carried out on Se species in relation to longevity.
In order to fill this gap, Se speciation in large multicenter studies focused on aging is desirable. Speciation of Se is generally performed with accurate but sophisticated procedures [20,21,22], which may prevent their usage in large multicenter studies that include thousands of subjects and limited amounts of plasma for the analysis. However, this problem has been recently overcome using micro separation techniques coupled with inductively coupled plasma mass spectrometry (ICP-MS) [23]. In the present study, we applied this procedure to investigate plasma Se and Se fractions on a large scale of subjects, including community-dwelling older adults (Randomly recruited Age-Stratified Individuals from the General population [RASIG]), GO (offspring of nonagenarians), and spouses of GO (SGO) recruited in the framework of the European MARK-AGE project [24,25].

2. Materials and Methods

2.1. Study Population, Recruitment, Data and Blood Collection

MARK-AGE is a European-wide cross-sectional population study aimed at the identification of biomarkers of aging [24,25]. In the present work, we used plasma samples from a total of 3007 donors in the age range of 35–75 years recruited in eight different European countries.
Details of the recruitment procedures and of the collection of anthropometric, clinical, and demographic data have been previously published [26,27]. The plasma isolation procedure from blood, as well as the shipment and distribution of biological samples, have been described [26]. Briefly, lithium heparin plasma was prepared from whole blood, obtained using phlebotomy after overnight fasting, and subsequently stored at −80 °C. Samples were then shipped from the various recruitment centers to the MARK-AGE Biobank located at the University of Hohenheim, Stuttgart, Germany. From the Biobank, coded samples were subsequently sent to the IRCCS INRCA on dry ice, where they were stored at −80°C until use.

2.2. Determination of Se in Plasma and Fractionation Analysis

Plasma Se levels were determined using a Thermo XII Series ICP–MS device (Thermo Electron, Waltham, MA, USA) as previously reported [23]. Plasma samples were centrifuged at 20,000× g for 10 min, and the supernatants were diluted 1:20 (total volume 1 mL) with a diluent containing 0.1% Triton X-100 (BDH Chemicals), 0.1% Trace Select Ultra HNO3 (Sigma–Aldrich), and 10 ppb Rh (Merck) as the internal standard. External multielement calibration solutions containing Fe, Zn, Cu, and Se (blank and 0.5–500 ppb) were prepared via serial dilution of a parent multielement solution (Inorganic Ventures) using the same diluent used for the samples. The ICP-MS was set by using Collision cell technology (CCT) with kinetic energy discrimination (KED) with a gas mixture containing 8% H2 in He in order to avoid polyatomic interferences. Data (three repeats per sample) were acquired for 80Se.
The fractionation analysis was performed by coupling anion exchange HPLC to ICP–MS following the procedure already published by the authors in 2012 [23]. Briefly, plasma samples were injected directly into a monolithic anion exchange micro column (Dionex ProSwift SAX1-S, 1x50 mm i.d.). The buffers used for the chromatographic separation were 10 mM Tris (pH 7.4) (buffer A) and 1 M ammonium acetate in 10 mM Tris (pH 7.4) (buffer B). The HPLC separation of metal fractions was optimized at a flow rate of 0.2 mL/min, linearly increasing the concentration of buffer B from 0% (100% buffer A) to 60% (40% buffer A) in 10 min (“elution program”). A tandem LC mode was used to save the time needed for washing and regenerating the columns after each run. In tandem LC mode, two identical columns are switched between two flow paths: an analysis flow path and a regeneration flow path to allow column washing and re-equilibration off-line. While one column was equilibrated, the system injected the next sample into the other. The program used to wash and regenerate the columns off-line was the following: 60% B to 100% B in 0.5 min, hold 4 min, return to 0% B in 0.5 min, and equilibrate with 0% B for 5 min. The interface between the LC system and the ICP–MS device for automated run and acquisition of chromatograms was performed with an external trigger card included in an LC coupling kit (Thermo Fischer).
The ICP-MS was set by using CCT and the same gas mixture used for Se plasma determination. Data were acquired for 78Se. The main fraction of Se (Se1) eluted after 2.5 min, with a second small peak (Se2) eluting at 5.3 min. Se1 and Se2 areas were defined following the retention times already considered in the methodological manuscript [23]. The relative percentage of the areas under the peaks was used for the analysis.

2.3. Statistical Analysis

Characteristics of the population studied were described using means and SD for continuous variables (age, BMI) and frequencies (%) for the categorical variables (sex, BMI classes, age class, groups, and country). The identification of potential critical variables that can affect the levels of Se was performed via non-parametric test (test of Kruskal–Wallis or Mann–Whitney U for two comparisons of the group) and Generalized Linear Models (GLMs) including age, gender, BMI, and country effects. Se plasma levels did not follow a normal distribution (Kolgomorov–Smirnov test) considering the whole population, but the data displayed a normal distribution when considered within age classes and country, particularly after log transformation. Critical variables identified by non-parametric tests and GLMs were subsequently included as covariates in additional GLM models to establish the influence of major confounders on target variables (age classes and subject groups). For this analysis, log transformation was applied to all continuous variables included in the analysis. Pairwise comparisons (Bonferroni’s method for GLM tests) were used to identify significant differences between percentile groups of each categorized variable. Linear regression analysis among plasma Se levels and other continuous variables was performed with a bootstrap procedure (1000 samples) stratified by the major categorical factors affecting the target variables. Multivariate stepwise linear regression analysis was also performed to investigate the association among plasma Se levels with glucometabolic, inflammatory, and anti-inflammatory parameters. The variables included were age, sex, country, food consumption, smoking habit, alcohol consumption, body mass index (BMI), lipid profile, albumin, glucometabolic parameters (fasting blood glucose, glycosylated hemoglobin, insulin), inflammatory parameters (C-reactive protein, fibrinogen, homocysteine, ceruloplasmin), and anti-inflammatory parameters (adiponectin). All statistical analysis (excluding analysis of batch effects) was carried out using SPSS software (SPSS Inc., Chicago, IL, USA; Version 23.0).

3. Results

3.1. Characteristics of the Study Population

The analysis of plasma Se levels was performed on samples obtained from donors (3007 individuals) from eight European countries. Characteristics of the study population are summarized in Supplementary Table S1. A total of 2200 subjects were from the RASIG subpopulation, representing individuals from the general population. A total of 514 subjects were from the nonagenarian offspring subpopulation called GO (“GEHA offspring “). These subjects had a long-lived parent who had previously been enrolled in the project GEHA [28]. GO are considered as a potential model of “delayed aging”, based on the assumption that their genetic background may predispose them to longevity. A total of 293 spouses of GO (SGO) [24,25] were included as a control for environmental factors and lifestyle. The MARK-AGE subjects covered the age range between 35 and 75 years and were stratified into four 10-year age groups. The age distribution of RASIG individuals was almost homogeneous, while GO and SGO individuals fell into age ranges greater than 54 years. The distribution of GO, SGO, and RASIG among the recruiting centers is reported in Supplementary Table S2.
The composition of males and females was mainly comparable in all age groups. In accordance with a previous investigation on the MARK-AGE population [29] and with the literature data, the body mass index (BMI) increased with age from 35 to 75 years, indicating that the analyzed population was effectively representative of a physiological aging process (Supplementary Table S1). The characteristics of the study population referred to each recruiting center were similar to previous published data [29].

3.2. Levels of Plasma Se Concentrations According to Age and Demographics

In the RASIG plasma, Se displays a non-normal distribution across the whole population (by Kolmogorov–Smirnov test and Shapiro–Wilk test). However, when we performed the test of normality separating the dependent variables into subgroups (considering center, age group, and experimental groups), all variables showed a normal distribution in the majority of subgroups, with few exceptions. This can be also seen from the similar values of the means reported in Table 1 and the medians reported in Supplementary Table S3. Nevertheless, we used both parametric (e.g., Generalized Linear Models) (Table 2) and non-parametric analyses (e.g., Kruskal–Wallis in Supplementary Table S3) to confirm the results.
The levels of plasma Se in RASIG display modest changes with age, best modelled with a non-linear pattern (Supplementary Figure S1), with a slight increase in the 55–64-year class compared to the youngest and oldest age classes (Table 1). However, sex stratification revealed that Se plasma levels decreased linearly with age in males (coefficient: −0.086, p < 0.05, by generalized linear mixed model adjusted for BMI, country, fish and vitamin consumption), while females showed a U-shape trend (Figure 1). Males older than 65 years had lower Se plasma levels than subjects in the 35–44 age group (p < 0.05).
Females in the 35–44 age group had lower Se plasma levels than those in the 45–54 and 55–64 age groups (p < 0.0001), while old females over 65 showed reduced Se plasma levels compared to those in the 45–54 (p < 0.05) and 55–64 (p = 0.001) age groups. Due to this different pattern, sex differences were observed in the age class 35–44 (males higher than females, p < 0.001) and in the age class 55–64 (females higher than males, p < 0.001), not taking into account the whole population (Table 1).
Recruitment center had a strong effect on plasma Se, with the highest levels observed in Finland and the lowest levels in Poland. Plasma Se levels were inversely related to BMI, with the lowest levels observed in the ≥30 BMI class (Table 1).

3.3. Influence of Dietary and Inherited Factors on Plasma Se Levels

Since plasma Se levels are expected to change according to dietary habits, we carried out an automated regression analysis of plasma Se including fruit, vitamin, vegetables, bread, meat, fish, eggs, and dairy products consumption. According to this exploratory analysis, the two major dietary factors affecting plasma Se levels were fish and vitamin consumption (Supplementary Table S4).
Hence, we included these factors and the subject groups (GO, SGO, RASIG) in a multivariate analysis of plasma Se, performed on the whole population with the aim to investigate the respective influence of the inherited “longevity background” and dietary habits on these variables (Supplementary Table S5). Plasma Se levels were not different between the RASIG, GO, and SGO groups, but they were influenced by dietary habits (p < 0.001). Plasma Se levels, in relation to vitamin and fish consumption and subject groups, are also represented in Figure 2, which shows an increment of this metal trace element in RASIG and GO subjects who take more vitamins or consume more fish. In Supplementary Figure S2, plasma Se levels in the whole population in relation to vitamin and fish consumption after country stratification are also displayed.

3.4. Selenium Fractions in MARK-AGE Population

The % distribution of Se, among the fractions identified in plasma by our HPLC system, was performed following the nomenclature previously assigned without identification of the representative selenoproteins [23]. The method can separate three peaks, specifically the Se1a, Se1b, and Se2 peaks. The latter is mirrored in Se1a + Se1b (as their sum is 100%).
In the RASIG population, Generalized Linear Models analysis showed that younger females had lower Se1a percentages than those in the 45–54 and 55–64 age groups (p < 0.01), while Se1a in males did not change in relation to age groups (Supplementary Figure S3A). Se1b was lower in younger females compared to those in the 65–75 age class (p < 0.05). No significant differences were found in males (Supplementary Figure S3B). Moreover, after sex stratification, Se2 decreased linearly with age in females (coefficient: −0.058, p < 0.05, by generalized linear mixed model adjusted for BMI, country, fish and vitamin consumption), while males showed an inverted U-shape trend (Figure 3A).
Females in the 35–44 age group had lower Se2 than those in the 55–64 (p < 0.01) and 65–75 (p < 0.05) age groups. Males in the 45–54 age group had higher Se2 than subjects in the 35–44 and 55–64 age groups (p < 0.05).
Se1b and Se2 percentages significantly differ between subject groups, independent of nutritional or other confounding factors (generalized linear mixed model adjusted for age, gender, country, BMI, fish and vitamin consumption). Se2 was higher in RASIG compared to GO and SGO (Figure 3B), while after country stratification, Se2 was augmented in RASIG compared to GO in Italy, Greece, and Belgium (Supplementary Figure S4). Se1b was significantly lower in RASIG than in GO and SGO subjects (p < 0.05), while Se1a was similar between subject groups (Supplementary Figure S5). In Supplementary Figure S6 is depicted a representative comparison between RASIG (red line) and GO (black line) Se chromatographic separations.

3.5. Association of Glucometabolic, Inflammatory, and Anti-Inflammatory Factors with Plasma Se Levels and Se2 Fraction

Independent glucometabolic and inflammatory markers associated with plasma Se levels and Se2 fraction (dependent variable) were identified with a linear regression analysis using the stepwise method (Table 2). We observed a positive association for Se plasma levels with albumin levels (p < 0.0001), HDL total cholesterol, fibrinogen (p < 0.01), and triglycerides (p < 0.05) and a negative association with homocysteine (p < 0.05). No association was found with circulating concentrations of fasting blood glucose, glycosylated hemoglobin (HbA1c), C-reactive protein, ceruloplasmin, and adiponectin.
Se2 was negatively associated with fibrinogen (p < 0.0001) and positively associated with adiponectin (p < 0.0001), H1Abc (p < 0.01), and ceruloplasmin (p < 0.01).

4. Discussion

In the present work, we evaluated plasma Se levels and individual Se fractions in relation to aging and longevity, considering the effect of countries and dietary habits, as well as the association of plasma Se concentrations and Se2 fraction with glucometabolic, inflammatory, and anti-inflammatory factors. Plasma Se varied greatly in relation to the country of residence, and subjects from Finland in particular showed the highest plasma Se, while those from Poland had the lowest values. The relatively low levels of Se observed in the other countries (Greece, Poland, and Austria) might suggest the use of Se biofortification to produce Se-enriched foods for counteracting Se deficiency. Consumption of Se-biofortified wheat or maize flour showed an improvement in the Se status [30,31], although no influence has been observed on biomarkers of cardiovascular disease risk, oxidative stress, and immune function [31]. The highest Se levels in Finland and Italy could just be related to the implementation of a nationwide Se fertilization program [32] or biofortification of potatoes, onions, or carrots [33], respectively.
However, circulating trace elements, including Se, are very responsive to aging and many other physio-pathological changes occurring with aging, independently of nutrition. Moreover, we did not perform a recruitment in order to be representative for the whole population in each country. Hence, further studies are needed before providing definitive population-tailored advice on Se biofortification.
In the RASIG subjects, plasma Se levels were associated with age; after sex stratification, plasma Se decreased linearly with aging in males, while females showed a U-shape trend. Other investigations have reported a decrement in blood Se with age. Results from the EPIC-Potsdam cohort study show a decrease in serum Se concentrations in a German population of healthy septuagenarian subjects over a 20-year follow-up period [34]. Another study, in a Chinese population in the age range 65–102 years, shows an age-related decrease in blood Se concentrations [35]. In contrast to our work, however, those studies were focused on old or very old subjects and did not cover the younger age range in females, where we found that Se levels in our population were similar in younger females compared to those in the 65–75 age range. The apparent discrepancies may depend on the differences in environmental factors, lifestyle, and dietary habits, but also on the influence of the estrogen levels on Se metabolism and tissue distribution [36].
Regarding the effect of dietary habits, we found that higher fish and vitamin consumption is associated with increased plasma Se levels, as also supported by other investigations [22,37]. In fact, studies on dietary Se intake showed that fish represents one of the main contributors to Se dietary intake in European populations [38].
We found no significant differences in plasma Se concentrations between RASIG, GO, and SGO, while differences were found in Se fractionation between subject groups.
To our knowledge, this is the first study to investigate the Se fractionation in elderly subjects from long-lived families. We have found significant differences in the percentage of Se2, which was higher in RASIG compared to GO and SGO subjects, suggesting an effect of lifestyle and dietary habits on Se fractionation, whereas a minor influence seems to be exerted by genetics. The lack of differences between Se plasma levels and its fractions in GO and SGO participants is not surprising because, as previously observed in other studies within the MARK-AGE project, these parameters may depend on sharing a common environment, diet, and lifestyle factors [29,39,40]. Importantly, in this study, we were not able to identify all Se fractions coeluting with the three major peaks, and thus the contribution of minor species to the observed differences cannot be excluded.
However, Se is known to be bound to plasma glutathione peroxidase (Se-GpX, 15–25%), selenoprotein P (50–60%), and albumin (10–20%) [41]. As the first peak of Se (Se1) coelutes with the big fraction of zinc, we can suppose that Se1 might include Se bound to albumin [23]. Given that SELENOP is the major selenoprotein in plasma and contains ten selenocysteine residues (compared to only four in GPx), it is conceivable that Se1a (the most abundant peak) corresponds to SELENOP, while Se1b corresponds to SeAlb. The positive association between Se1a and serum albumin levels (Supplementary Figure S7) does not contradict this hypothesis, as a correlation between these two proteins has also been documented by others [42]. However, further investigations combining this separation with molecular mass spectrometry or other detection systems [43,44] will be required to precisely identify these Se species.
Interestingly, the relative percentage of Se1a showed a linear increase with age in females, in agreement with a previous observation supporting an age-related increase in this protein [45]. The linear decrease in Se1b percentage with age in females could be in line with previous results demonstrating an inverse association between Se-dependent GPx and age in a cohort of 601 women older than 65 years of age [46], while the lack of association between Se fractions and age in males may be consistent with previous findings [22], especially after adjusting for confounding factors.
Our results also support other evidence indicating an inverse relationship between plasma Se levels and BMI [47]. A positive association was also observed between plasma Se levels and total cholesterol, HDL, triglycerides, and fibrinogen, as also reported by other authors [48,49].
A recent study on a large Chinese cohort has shown that higher blood Se levels are associated with a significantly lower risk of prevalent hyperhomocysteinemia [50]. In line with those results, we observed a significant negative association between plasma Se and serum homocysteine.
No significant association was found with inflammatory (CRP and ceruloplasmin) and anti-inflammatory (adiponectin) parameters, although some evidence was reported for increased inflammation in the presence of Se deficiency [5]. The lack of association between Se plasma concentration and glycemic biomarkers would seem contradictory with some studies where this relationship has been observed [51,52]. However, the results remain controversial [53], reporting sex differences [54] or association in diabetic patients, but not in healthy subjects [55].
Interestingly, Se2 fraction was negatively associated with fibrinogen and positively associated with adiponectin, H1Abc, and ceruloplasmin. In support of these findings, other studies report a negative association between fibrinogen and Se-dependent Gpx levels in patients with stroke or age-related macular degeneration [56,57] and a direct relationship between the overexpression of Se-dependent Gpx and the development of insulin resistance and diabetes in mice models [58,59].
In conclusion, these findings show that sex-specific, nutritional, and inflammatory factors play a crucial role in the regulation of Se plasma levels throughout the aging process and that the shared environment of GO and SGO plays a role in their distinctive Se fractionation.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu15092182/s1. Table S1. Description of the population under examination. Table S2. Distribution of GO, SGO and RASIG subjects in relation to age groups and countries. Table S3. Effect of age, sex, BMI on serum Se in the RASIG population. Table S4. Association of dietary habits with Plasma Se in Mark-age population. Table S5. Contribution of dietary factors and subject groups (GO, RASIG and SGO) to plasma Se levels by multivariate analysis. Figure S1. Linear regression between Plasma Se and age in RASIG population. Figure S2. Plasma Se levels in MARK-AGE population in relation to vitamin and fish consumption after country stratification. Figure S3. Se1a and Se1b percentages in RASIG participants stratified by sex. Figure S4. Se2 in MAR-AGE population after country stratification. Figure S5. Se1a and Se1b percentages in GO, SGO and RASIG participants. Figure S6. Selenium chromatographic separation. Figure S7. Linear regression between Se1a and albumin in RASIG population.

Author Contributions

Conceptualization, R.G., F.P. and M.M.; Methodology, F.P. and M.M.; Software, R.G., V.A., M.M. and M.M.V.; BioBank, T.G.; Recruitment of subjects, B.W. (Austrian cohort), O.T. and F.D.-C. (Belgian cohort), J.B. (German cohort), E.S.G. (Greek cohort), C.F. and M.C. (Italian cohort), E.S. (Polish cohort); Validation, F.P. and M.M.; Formal analysis, M.P., A.B., M.M.V., W.S., T.G., M.E.T.D. and P.E.S.; Investigation, R.G., V.A., and F.P.; Resources, A.B., M.Z., and M.P.; Data Curation, R.G., F.P., M.M., M.E.T.D., M.M.V. and E.J.; Writing—Original draft preparation, R.G. and V.A., Writing—review and editing, R.G., M.Z., M.P., A.B., M.M.V., M.M., F.P. and M.L.F.-S.; Supervision, M.M.; Project administration, A.B.; Funding acquisition, A.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the European Commission (Project Full Name: European Study to Establish Biomarkers of Human Ageing; Project Acronym: MARK-AGE; Project No: 200880) and by the Italian Health Ministry with the Ricerca corrente project: Programmazione triennale IRCCS 2022-2024.

Institutional Review Board Statement

All information was accessed in accordance with the applicable laws and ethical requirements for the study period concerned and was compliant with the Declaration of Helsinki. The Local Research Ethics Committees of the respective recruiting centers provided ethical approval for the MARK-AGE project, which was registered retrospectively at the German Clinical Trials Register (DRKS00007713; Ethics Committee No.: 2008-075-f, Ethik-Kommission bei der Landesärztekammer Baden-Württemberg).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The datasets analyzed in this study are available from the corresponding authors upon reasonable request.

Acknowledgments

The authors thank the subjects who participated in the MARK-AGE study; a special thanks to the late Oliver Toussaint, who dedicated his life to research activity with great energy, creativity, and enthusiasm. We remember him with great admiration and affection.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Roman, M.; Jitaru, P.; Barbante, C. Selenium biochemistry and its role for human health. Metallomics 2014, 6, 25–54. [Google Scholar] [CrossRef] [PubMed]
  2. Papp, L.V.; Lu, J.; Holmgren, A.; Khanna, K.K. From Selenium to Selenoproteins: Synthesis, Identity, and Their Role in Human Health. Antioxid. Redox Signal 2007, 9, 75–806. [Google Scholar] [CrossRef]
  3. Rayman, M.P. The importance of selenium to human health. Lancet 2000, 356, 33–241. [Google Scholar] [CrossRef] [PubMed]
  4. Rayman, M.P. Selenium and human health. Lancet 2012, 379, 1256–1268. [Google Scholar] [CrossRef]
  5. Giacconi, R.; Chiodi, L.; Boccoli, G.; Costarelli, L.; Piacenza, F.; Provinciali, M.; Malavolta, M. Reduced levels of plasma selenium are associated with increased inflammation and cardiovascular disease in an Italian elderly population. Exp. Gerontol. 2021, 145, 111219. [Google Scholar] [CrossRef]
  6. Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; National Academies Press: Washington, DC, USA, 2000. [Google Scholar] [CrossRef]
  7. Akbaraly, N.T.; Arnaud, J.; Hininger-Favier, I.; Gourlet, V.; Roussel, A.-M.; Berr, C. Selenium and mortality in the elderly: Results from the EVA study. Clin. Chem. 2005, 51, 2117–2123. [Google Scholar] [CrossRef]
  8. Alis, R.; Santos-Lozano, A.; Sanchis-Gomar, F.; Pareja-Galeano, H.; Fiuza-Luces, C.; Garatachea, N.; Lucia, A.; Emanuele, E. Trace elements levels in centenarian ‘dodgers’. J. Trace Elem. Med. Biol. 2016, 35, 103–106. [Google Scholar] [CrossRef]
  9. Mocchegiani, E.; Malavolta, M. Role of Zinc and Selenium in Oxidative Stress and Immunosenescence: Implications for Healthy Aging and Longevity. In Handbook of Immunosenescence; Springer International Publishing: Cham, Switzerland, 2018; pp. 1–35. [Google Scholar] [CrossRef]
  10. Robberecht, H.; De Bruyne, T.; Davioud-Charvet, E.; Mackrill, J.; Hermans, N. Selenium Status in Elderly People: Longevity and Age-Related Diseases. Curr. Pharm Des. 2019, 25, 1694–1706. [Google Scholar] [CrossRef] [PubMed]
  11. Thomson, C.D. Assessment of requirements for selenium and adequacy of selenium status: A review. Eur. J. Clin. Nutr. 2004, 58, 91–402. [Google Scholar] [CrossRef]
  12. Johnson, C.C.; Fordyce, F.M.; Rayman, M.P. Symposium on ‘Geographical and geological influences on nutrition’: Factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc. Nutr. Soc. 2010, 69, 119–132. [Google Scholar] [CrossRef] [PubMed]
  13. Navarro-Alarcon, M.; Cabrera-Vique, C. Selenium in food and the human body: A review. Sci. Total Environ. 2008, 400, 115–141. [Google Scholar] [CrossRef]
  14. Mocchegiani, E.; Costarelli, L.; Giacconi, R.; Malavolta, M.; Basso, A.; Piacenza, F.; Ostan, R.; Cevenini, E.; Gonos, E.S.; Monti, D. Micronutrient-gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A systematic review. Mech. Ageing Dev. 2014, 136–137, 29–49. [Google Scholar] [CrossRef] [PubMed]
  15. Weekley, C.M.; Harris, H.H. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem. Soc. Rev. 2013, 42, 870. [Google Scholar] [CrossRef]
  16. Kryukov, G.V.; Castellano, S.; Novoselov, S.V.; Lobanov, A.V.; Zehtab, O.; Guigó, R.; Gladyshev, V.N. Characterization of mammalian selenoproteomes. Science 2003, 300, 439–1443. [Google Scholar] [CrossRef] [PubMed]
  17. Del Castillo Busto, M.E.; Oster, C.; Cuello-Nuñez, S.; Deitrich, C.L.; Raab, A.; Konopka, A.; Lehmann, W.D.; Goenaga-Infante, H.; Fisicaro, P. Accurate quantification of selenoproteins in human plasma/serum by isotope dilution ICP-MS: Focus on selenoprotein P. J. Anal. Spectrom. 2016, 31, 1904–1912. [Google Scholar] [CrossRef]
  18. Alehagen, U.; Opstad, T.B.; Alexander, J.; Larsson, A.; Aaseth, J. Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. Rev. Biomol. 2021, 11, 1478. [Google Scholar] [CrossRef]
  19. Forte, G.; Deiana, M.; Pasella, S.; Baralla, A.; Occhineri, P.; Mura, I.; Madeddu, R.; Muresu, E.; Sotgia, S.; Zinellu, A.; et al. Metals in plasma of nonagenarians and centenarians living in a key area of longevity. Exp. Gerontol. 2014, 60, 197–206. [Google Scholar] [CrossRef]
  20. de González Vega, R.; Fernández-Sánchez, M.L.; González Iglesias, H.; Coca Prados, M.; Sanz-Medel, A. Quantitative selenium speciation by HPLC-ICP-MS(IDA) and simultaneous activity measurements in human vitreous humor. Anal. Bioanal. Chem. 2015, 407, 2405–2413. [Google Scholar] [CrossRef] [PubMed]
  21. Michalke, B.; Berthele, A. Contribution to selenium speciation in cerebrospinal fluid samples. J. Anal. At. Spectrom. 2011, 26, 165–170. [Google Scholar] [CrossRef]
  22. Vinceti, M.; Grill, P.; Malagoli, C.; Filippini, T.; Storani, S.; Malavolti, M.; Michalke, B. Selenium speciation in human serum and its implications for epidemiologic research: A cross-sectional study. J. Trace Elem. Med. Biol. 2015, 31, 1–10. [Google Scholar] [CrossRef]
  23. Malavolta, M.; Piacenza, F.; Basso, A.; Giacconi, R.; Costarelli, L.; Pierpaoli, S.; Mocchegiani, E. Speciation of trace elements in human serum by micro anion exchange chromatography coupled with inductively coupled plasma mass spectrometry. Anal. Biochem. 2012, 421, 16–25. [Google Scholar] [CrossRef] [PubMed]
  24. Bürkle, A.; Moreno-Villanueva, M.; Bernhard, J.; Blasco, M.; Zondag, G.; Hoeijmakers, J.H.; Toussaint, O.; Grubeck-Loebenstein, B.; Mocchegiani, E.; Collino, S.; et al. MARK-AGE biomarkers of ageing. Mech. Ageing Dev. 2015, 151, 2–12. [Google Scholar] [CrossRef]
  25. Capri, M.; Moreno-Villanueva, M.; Cevenini, E.; Pini, E.; Scurti, M.; Borelli, V.; Palmas, M.G.; Zoli, M.; Schön, C.; Siepelmeyer, A.; et al. MARK-AGE population: From the human model to new insights. Mech. Ageing Dev. 2015, 151, 13–17. [Google Scholar] [CrossRef]
  26. Moreno-Villanueva, M.; Capri, M.; Breusing, N.; Siepelmeyer, A.; Sevini, F.; Ghezzo, A.; de Craen, A.J.M.; Hervonen, A.; Hurme, M.; Schön, C.; et al. MARK-AGE standard operating procedures (SOPs): A successful effort. Mech. Ageing Dev. 2015, 151, 18–25. [Google Scholar] [CrossRef]
  27. Moreno-Villanueva, M.; Kötter, T.; Sindlinger, T.; Baur, J.; Oehlke, S.; Bürkle, A.; Berthold, M.R. The MARK-AGE phenotypic database: Structure and strategy. Mech. Ageing Dev. 2015, 151, 26–30. [Google Scholar] [CrossRef]
  28. Franceschi, C.; Bezrukov, V.; Blanché, H.; Bolund, L.; Christensen, K.; de Benedictis, G.; Deiana, L.; Gonos, E.; Hervonen, A.; Yang, H.; et al. Genetics of healthy aging in Europe: The EU-integrated project GEHA (GEnetics of Healthy Aging). Ann. N. Y. Acad. Sci. 2007, 1100, 21–45. [Google Scholar] [CrossRef] [PubMed]
  29. Ciccarone, F.; Malavolta, M.; Calabrese, R.; Guastafierro, T.; Bacalini, M.G.M.G.; Reale, A.; Franceschi, C.; Capri, M.; Hervonen, A.; Hurme, M.; et al. Age-dependent expression of DNMT1 and DNMT3B in PBMCs from a large European population enrolled in the MARK-AGE study. Aging Cell 2016, 15, 755–765. [Google Scholar] [CrossRef]
  30. Joy, E.J.M.; Kalimbira, A.A.; Sturgess, J.; Banda, L.; Chiutsi-Phiri, G.; Manase, H.; Gondwe, J.; Ferguson, E.L.; Kalumikiza, Z.; Bailey, E.H.; et al. Biofortified Maize Improves Selenium Status of Women and Children in a Rural Community in Malawi: Results of the Addressing Hidden Hunger with Agronomy Randomized Controlled Trial. Front Nutr. 2022, 8, 788096. [Google Scholar] [CrossRef] [PubMed]
  31. Wu, J.; Salisbury, C.; Graham, R.; Lyons, G.; Fenech, M. Increased consumption of wheat biofortified with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males. Env. Mol. Mutagen. 2009, 50, 489–501. [Google Scholar] [CrossRef]
  32. Stoffaneller, R.; Morse, N.L.A. Review of dietary selenium intake and selenium status in Europe and the Middle East. Nutrients 2015, 7, 1494–1537. [Google Scholar] [CrossRef]
  33. D’Amato, R.; Regni, L.; Falcinelli, B.; Mattioli, S.; Benincasa, P.; Dal Bosco, A.; Pacheco, P.; Proietti, P.; Troni, E.; Santi, C.; et al. Current Knowledge on Selenium Biofortification to Improve the Nutraceutical Profile of Food: A Comprehensive Review. J. Agric. Food Chem. 2020, 68, 4075–4097. [Google Scholar] [CrossRef] [PubMed]
  34. Baudry, J.; Kopp, J.F.; Boeing, H.; Kipp, A.P.; Schwerdtle, T.; Schulze, M.B. Changes of trace element status during aging: Results of the EPIC-Potsdam cohort study. Eur. J. Nutr. 2020, 59, 3045–3058. [Google Scholar] [CrossRef]
  35. Lv, Y.; Wei, Y.; Zhou, J.; Xue, K.; Guo, Y.; Liu, Y.; Ju, A.; Wu, B.; Zhao, F.; Chen, C.; et al. Human biomonitoring of toxic and essential metals in younger elderly, octogenarians, nonagenarians and centenarians: Analysis of the Healthy Ageing and Biomarkers Cohort Study (HABCS) in China. Environ. Int. 2021, 156, 106717. [Google Scholar] [CrossRef]
  36. Zhou, X.; Smith, A.M.; Failla, M.L.; Hill, K.E.; Yu, Z. Estrogen status alters tissue distribution and metabolism of selenium in female rats. J. Nutr. Biochem. 2012, 23, 532–538. [Google Scholar] [CrossRef] [PubMed]
  37. Berr, C.; Akbaraly, T.; Arnaud, J.; Hininger, I.; Roussel, A.M.; Barberger Gateau, P. Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids. J. Nutr. Health Aging 2009, 3, 14–18. [Google Scholar] [CrossRef] [PubMed]
  38. Filippini, T.; Michalke, B.; Wise, L.A.; Malagoli, C.; Malavolti, M.; Vescovi, L.; Salvia, C.; Bargellini, A.; Sieri, S.; Krogh, V.; et al. Diet composition and serum levels of selenium species: A cross-sectional study. Food Chem. Toxicol. 2018, 115, 482–490. [Google Scholar] [CrossRef] [PubMed]
  39. Piacenza, F.; Giacconi, R.; Costarelli, L.; Basso, A.; Bürkle, A.; Moreno-Villanueva, M.; Dollé, M.E.T.; Jansen, E.; Grune, T.; Weber, D.; et al. Age, Sex, and BMI Influence on Copper, Zinc, and Their Major Serum Carrier Proteins in a Large European Population Including Nonagenarian Offspring from MARK-AGE Study. J. Gerontol. Ser. A 2021, 76, 2097–2106. [Google Scholar] [CrossRef]
  40. Giacconi, R.; D’Aquila, P.; Malavolta, M.; Piacenza, F.; Bürkle, A.; Villanueva, M.M.; Dollé, M.E.T.; Jansen, E.; Grune, T.; Gonos, E.S.; et al. Bacterial DNAemia in Older Participants and Nonagenarian Offspring and Association with Redox Biomarkers: Results from MARK-AGE Study. J. Gerontol. A Biol. Sci. Med. Sci. 2023, 78, 42–50. [Google Scholar] [CrossRef]
  41. Muñiz, C.S.; Marchante-Gayón, J.M.; García Alonso, J.; Sanz-Medel, A. Speciation of essential elements in human serum using anion exchange chromatography coupled to post-column isotope dilution analysis with double focusing ICP–MS. J. Anal. At. Spectrom. 2001, 16, 587–592. [Google Scholar] [CrossRef]
  42. Persson-Moschos, M.E.; Stavenow, L.; Akesson, B.; Lindgärde, F. Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men. Nutr. Cancer 2000, 36, 19–26. [Google Scholar] [CrossRef]
  43. Jitaru, P.; Goenaga-Infante, H.; Vaslin-Reimann, S.; Fisicaro, P. A systematic approach to the accurate quantification of selenium in serum selenoalbumin by HPLC-ICP-MS. Anal. Chim. Acta. 2010, 657, 100–107. [Google Scholar] [CrossRef] [PubMed]
  44. Cardoso, B.R.; Ganio, K.; Roberts, B.R. Expanding beyond ICP-MS to better understand selenium biochemistry. Metallomics 2019, 11, 1974–1983. [Google Scholar] [CrossRef] [PubMed]
  45. Krassas, G.E.; Pontikides, N.; Tziomalos, K.; Tzotzas, T.; Zosin, I.; Vlad, M.; Luger, A.; Gessl, A.; Marculescu, R.; Toscano, V.; et al. Selenium status in patients with autoimmune and non-autoimmune thyroid diseases from four European countries. Expert Rev. Endocrinol. Metab. 2014, 9, 685–692. [Google Scholar] [CrossRef] [PubMed]
  46. Espinoza, S.E.; Guo, H.; Fedarko, N.; DeZern, A.; Fried, L.P.; Xue, Q.L.; Leng, S.; Beamer, B.; Walston, J.D. Glutathione peroxidase enzyme activity in aging. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63, 505–509. [Google Scholar] [CrossRef]
  47. Błażewicz, A.; Klatka, M.; Astel, A.; Korona-Glowniak, I.; Dolliver, W.; Szwerc, W.; Kocjan, R. Serum and urinary selenium levels in obese children: A cross-sectional study. J. Trace Elem. Med. Biol. 2015, 29, 116–122. [Google Scholar] [CrossRef]
  48. Chen, L.; Fan, Z.; Sun, X.; Qiu, W.; Mu, W.; Chai, K.; Cao, Y.; Wang, G.; Lv, G. Diet-derived antioxidants and nonalcoholic fatty liver disease: A Mendelian randomization study. Hepatol. Int. 2022. [Google Scholar] [CrossRef]
  49. Huang, Y.Q.; Shen, G.; Lo, K.; Huang, J.Y.; Liu, L.; Chen, C.L.; Yu, Y.L.; Sun, S.; Zhang, B.; Feng, Y.Q. Association of circulating selenium concentration with dyslipidemia: Results from the NHANES. J. Trace Elem. Med. Biol. 2020, 58, 126438. [Google Scholar] [CrossRef]
  50. Wang, T.; Su, L.; Chen, X.; Wang, S.; Han, X.; Cheng, Y.; Lin, S.; Ding, L.; Liu, J.; Chen, C.; et al. Higher blood selenium level is associated with lower risk of hyperhomocysteinemia in the elderly. J. Trace Elem. Med. Biol. 2023, 75, 127078. [Google Scholar] [CrossRef]
  51. Wang, X.L.; Yang, T.B.; Wei, J.; Lei, G.H.; Zeng, C. Association between serum selenium level and type 2 diabetes mellitus: A non-linear dose-response meta-analysis of observational studies. Nutr. J. 2016, 15, 48. [Google Scholar] [CrossRef]
  52. Yang, J.; Chen, E.; Choi, C.; Chan, K.; Yang, Q.; Rana, J.; Yang, B.; Huang, C.; Yang, A.; Lo, K. Cross-Sectional Association of Blood Selenium with Glycemic Biomarkers among U.S. Adults with Normoglycemia in the National Health and Nutrition Examination Survey 2013–2016. Nutrients 2022, 14, 3972. [Google Scholar] [CrossRef]
  53. Nunes, F.L.D.S.; Lima, S.C.V.C.; Lyra, C.O.; Marchioni, D.M.; Pedrosa, L.F.C.; Barbosa Junior, F.; Sena-Evangelista, K.C.M. The impact of essential and toxic elements on cardiometabolic risk factors in adults and older people. J. Trace Elem. Med. Biol. 2022, 72, 126991. [Google Scholar] [CrossRef]
  54. Lu, C.W.; Chang, H.H.; Yang, K.C.; Chiang, C.H.; Yao, C.A.; Huang, K.C. Gender Differences with Dose-Response Relationship between Serum Selenium Levels and Metabolic Syndrome-A Case-Control Study. Nutrients 2019, 11, 477. [Google Scholar] [CrossRef] [PubMed]
  55. Luan, F.; Chen, Y.; Xu, Y.; Jiang, X.; Liu, B.; Wang, Y. Associations between whole blood trace elements concentrations and HbA1c levels in patients with type 2 diabetes. Biometals 2022, 35, 1011–1022. [Google Scholar] [CrossRef]
  56. Chehaibi, K.; Trabelsi, I.; Mahdouani, K.; Slimane, M.N. Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients. J. Stroke Cereb. Dis. 2016, 25, 2585–2593. [Google Scholar] [CrossRef]
  57. Čolak, E.; Ignjatović, S.; Radosavljević, A.; Žorić, L. The association of enzymatic and non-enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration. J. Clin. Biochem. Nutr. 2017, 60, 100–107. [Google Scholar] [CrossRef]
  58. McClung, J.P.; Roneker, C.A.; Mu, W.; Lisk, D.J.; Langlais, P.; Liu, F.; Lei, X.G. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. USA 2004, 101, 8852–8857. [Google Scholar] [CrossRef] [PubMed]
  59. Wang, X.D.; Vatamaniuk, M.Z.; Wang, S.K.; Roneker, C.A.; Simmons, R.A.; Lei, X.G. Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia 2008, 51, 1515–1524. [Google Scholar] [CrossRef] [PubMed]
Nutrients 15 02182 g001 550
Figure 1. Plasma Se levels in RASIG population after sex stratification. Males over the age of 65 had lower Se plasma levels than subjects in the 35–44 age group (° p < 0.05), Females in the 35–44 age group had lower Se plasma levels than those in the 45–54 and 55–64 age groups (*** p < 0.0001), Females over 65 showed reduced Se plasma levels compared to those in the 45–54 (* p < 0.05) and 55–64 (** p = 0.001) age groups.
Figure 1. Plasma Se levels in RASIG population after sex stratification. Males over the age of 65 had lower Se plasma levels than subjects in the 35–44 age group (° p < 0.05), Females in the 35–44 age group had lower Se plasma levels than those in the 45–54 and 55–64 age groups (*** p < 0.0001), Females over 65 showed reduced Se plasma levels compared to those in the 45–54 (* p < 0.05) and 55–64 (** p = 0.001) age groups.
Nutrients 15 02182 g001
Nutrients 15 02182 g002 550
Figure 2. Plasma Se levels in MARK-AGE population in relation to vitamin and fish consumption. Plasma Se levels increased in RASIG and GO subjects who took more vitamins and consumed more fish. ** p < 0.0001 compared to no serv./day; <1 serv./day; * p < 0.01 compared to no serv./day ° p < 0.05 compared to <1 serv./weekly or never; °° p < 0.001 compared to <1 serv./weekly or never.
Figure 2. Plasma Se levels in MARK-AGE population in relation to vitamin and fish consumption. Plasma Se levels increased in RASIG and GO subjects who took more vitamins and consumed more fish. ** p < 0.0001 compared to no serv./day; <1 serv./day; * p < 0.01 compared to no serv./day ° p < 0.05 compared to <1 serv./weekly or never; °° p < 0.001 compared to <1 serv./weekly or never.
Nutrients 15 02182 g002
Nutrients 15 02182 g003 550
Figure 3. Se2 percentage in GO, SGO, and RASIG subjects in the whole sample and after sex stratification. Younger females had lower Se2 than those in the 55–64 and 65–75 age groups (** p < 0.01). Males in the 45–54 age group had higher Se2 than subjects in the 35–44 and 55–64 age groups (* p < 0.05, ((A) Relation of Se2 percentage with age after sex stratification in the whole sample). The percentage of Se2 fraction was higher in RASIG than GO and SGO ((B) Se2 percentage in GO, SGO and RASIG participants), * p < 0.05 compared to RASIG; ** p < 0.001 compared to RASIG.
Figure 3. Se2 percentage in GO, SGO, and RASIG subjects in the whole sample and after sex stratification. Younger females had lower Se2 than those in the 55–64 and 65–75 age groups (** p < 0.01). Males in the 45–54 age group had higher Se2 than subjects in the 35–44 and 55–64 age groups (* p < 0.05, ((A) Relation of Se2 percentage with age after sex stratification in the whole sample). The percentage of Se2 fraction was higher in RASIG than GO and SGO ((B) Se2 percentage in GO, SGO and RASIG participants), * p < 0.05 compared to RASIG; ** p < 0.001 compared to RASIG.
Nutrients 15 02182 g003
Table
Table 1. Effect of age, gender, country, and BMI on plasma Se concentrations in the RASIG population.
Table 1. Effect of age, gender, country, and BMI on plasma Se concentrations in the RASIG population.
StatNPlasma Se (ppb)
Mean ± SD or (CI 95%)		p
(GLM)
Age group (years)35–44a481112.09 ± 17.59 c<0.001
45–54b552114.71 ± 19.71
55–64c595115.13 ± 23.49 a,d
65–75d572112.27 ± 20.73 c
CenterFinlanda90133.24 ± 18.55 c,d,e,g,h<0.001
Italyb383127.57 ± 12.14 c,d,e,g,h
Austriac380107.11 ± 18.11 a,b,e,g
Greeced374105.02 ± 14.68 a,b,e,g
Polande37195.14 ± 17.26 a,b,c,d,g,h
The Netherlandsf--
Belgiumg254120.46 ± 25.47 a,b,c,d,g,h
Germanyh345107.15 ± 15.66 a,b,e,g
SexFa1133111.73 ± 20.790.57
Mb1064110.05 ± 20.56
BMI classes<25a988113.16 ± 20.08 c<0.001
25 to <30b826109.84 ± 21.53
≥30c378107.41 ± 19.92 a
Data are reported as uncorrected means ± SD. Statistical comparison was performed with Generalized Linear Models (GLMs) using a normal distribution with identity-link function model. Bonferroni test was used as post-hoc for pairwise comparisons. Significant different groups are identified by superscripts indicated in the column “stats”. For the investigation of age-group effect, the model included the effects of sex and recruitment center as factors and BMI (continuous variable). For the investigation of BMI class effects, the model included the effects of sex and recruitment center as factors and age (continuous variable). All other GLM models included the effects of sex and recruitment center as well as age and BMI (continuous variables) as covariates.
Table
Table 2. Multivariate stepwise linear regression analysis for glucometabolic, inflammatory, and anti-inflammatory parameters independently associated with plasma Se levels and Se2 fraction in the RASIG population.
Table 2. Multivariate stepwise linear regression analysis for glucometabolic, inflammatory, and anti-inflammatory parameters independently associated with plasma Se levels and Se2 fraction in the RASIG population.
Unstandardized CoefficientsStandardized Coefficients
Plasma Se LevelsBStd. ErrorBetap Value
Albumin1.3010.1440.197p < 0.0001
HDL3.9171.2430.0830.002
TC1.4840.4740.0730.002
Fibrinogen1.0480.3200.0710.001
Homocysteine−0.2000.078−0.0560.010
TG1.1550.5730.0480.044
Se2 fractionBStd. ErrorBetap value
Fibrinogen−0.5960.115−0.123p < 0.0001
Adiponectin0.1120.0230.124p < 0.0001
HbA1c0.8540.2510.0770.001
Ceruloplasmin0.0640.0230.0680.005
TC: total cholesterol, HDL: HDL cholesterol, TG: triglycerides, HbA1c: glycated hemoglobin.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Giacconi, R.; Piacenza, F.; Aversano, V.; Zampieri, M.; Bürkle, A.; Villanueva, M.M.; Dollé, M.E.T.; Jansen, E.; Grune, T.; Gonos, E.S.; et al. Uncovering the Relationship between Selenium Status, Age, Health, and Dietary Habits: Insights from a Large Population Study including Nonagenarian Offspring from the MARK-AGE Project. Nutrients 2023, 15, 2182. https://doi.org/10.3390/nu15092182

AMA Style

Giacconi R, Piacenza F, Aversano V, Zampieri M, Bürkle A, Villanueva MM, Dollé MET, Jansen E, Grune T, Gonos ES, et al. Uncovering the Relationship between Selenium Status, Age, Health, and Dietary Habits: Insights from a Large Population Study including Nonagenarian Offspring from the MARK-AGE Project. Nutrients. 2023; 15(9):2182. https://doi.org/10.3390/nu15092182

Chicago/Turabian Style

Giacconi, Robertina, Francesco Piacenza, Valentina Aversano, Michele Zampieri, Alexander Bürkle, María Moreno Villanueva, Martijn E. T. Dollé, Eugène Jansen, Tilman Grune, Efstathios S. Gonos, and et al. 2023. "Uncovering the Relationship between Selenium Status, Age, Health, and Dietary Habits: Insights from a Large Population Study including Nonagenarian Offspring from the MARK-AGE Project" Nutrients 15, no. 9: 2182. https://doi.org/10.3390/nu15092182

APA Style

Giacconi, R., Piacenza, F., Aversano, V., Zampieri, M., Bürkle, A., Villanueva, M. M., Dollé, M. E. T., Jansen, E., Grune, T., Gonos, E. S., Franceschi, C., Capri, M., Weinberger, B., Sikora, E., Toussaint, O., Debacq-Chainiaux, F., Stuetz, W., Slagboom, P. E., Bernhardt, J., ... Malavolta, M. (2023). Uncovering the Relationship between Selenium Status, Age, Health, and Dietary Habits: Insights from a Large Population Study including Nonagenarian Offspring from the MARK-AGE Project. Nutrients, 15(9), 2182. https://doi.org/10.3390/nu15092182

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop